This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 01/08/2021
Location: Virtual
Subject: COVID-19 Vaccines
FDA Participant/Group: PETER MARKS; BETH FRITSCH; DAYLE CRISTINZIO; LORRIE MCNEILL; JULIA TIERNEY;
Non FDA Participant/Group: Several stakeholders from the aging community

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 01/05/2021
Location: Virtual
Subject: National Academies of Medicine: Digital Health Sector Co-Lead Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 01/08/2021
Location: Virtual
Subject: Dairy Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Michael Dykes (International Dairy Foods Association);

Event Date: 01/08/2021
Location: Virtual
Subject: Food Safety Priorities
FDA Participant/Group: N/A
Non FDA Participant/Group: Approximately 20 executives from across the agricultural industry

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/06/2021
Location: Virtual
Subject: National Foundation for Infectious Diseases Webinar; COVID-19 Update - Vaccination Recommendations and Implementation
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 01/07/2021
Location: Virtual
Subject: Town Hall Meeting; Making It Plain - What Black America Needs to Know About COVID-19 and Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia

Event Date: 01/07/2021
Location: Virtual
Subject: Silicon Valley Bank Innovate Next; Shaken & Stirred - Vaccine Reality
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event